LFMDP
LifeMD, Inc.Preferred stock of LifeMD, Inc. · LFMD stock page →
$21.60 +0.30 (+1.41%)
Oct 26 4:00 PM ET · prev $21.30
Market cap
$1.0B
Small cap
1 year
−9.5%
from $23.86 · Oct 27
30 days
−6.7%
from $23.15
52-week range
$19.76–24.01
−10% from high · low Dec 17
Avg volume 20D
1.8K
Oct 6 spike 6.3K
Short interest
🔒 Subscribers only
Filing reports
1
analyzed by SecBot
SecBot read MIXED 1 report · latest
Balance 0 bearish · 0 bullish · 1 mixed oldest → newest, height = score
Avg score ·High conf. 1/1
Price
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
No data for this timeframe.
- R May 6 LifeMD reported Q1 2026 revenue of $50.2M, above the $48-49M guidanc…
- X Jul 31 Short interest jumps 44.0% to 2.8K
- X Aug 14 Short interest falls 70.9% to 820
- X Aug 31 Short interest jumps 296.0% to 3.2K
- X Sep 30 Short interest falls 37.8% to 1.6K
Signal stack
Where each data set points today.
- TrendDOWNTREND
6% below its 50-day average.
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 22, 2026 Dividend
May 6, 2026 SEC LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virt
LifeMD reported Q1 2026 revenue of $50.2M, above the $48-49M guidance range and consensus estimate of $48.9M, with…
8-K — Impact 6/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Sep 22, 2026
Dividend
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
NEW YORK, Sept. 22, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care and pharmacy services, today…
Aug 5, 2026
Earnings
UPDATE - LifeMD Reports Second Quarter 2026 Results
UPDATE this press release has been updated to remove a duplicate table.
Jun 22, 2026
Contract
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection
Landmark agreement between a leading virtual care company and a pharmaceutical manufacturer establishes an exclusive telehealth co-marketing…
Jun 1, 2026
Press release
LifeMD Appoints Umesh Sripad as Chief Technology Officer
Seasoned Technology Executive Brings More Than Two Decades of Large-Scale Digital Transformation Experience to Support LifeMD’s Next Phase of Growth…
May 15, 2026
Press release
LifeMD to Participate in Upcoming Investor Conferences
NEW YORK, May 15, 2026 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading platform for virtual primary care services, today announced that…
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $48.8M |
| Next Q | — | — | — | $61.5M |
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | — | — | — | $245.1M |
Short side
FINRA· Oct 15, 2026🔒 Subscribers only
shares short
SecBot reports
1 filing · 0 bullish · 0 bearish · 1 mixedAll LFMDP filing & press-release reports (1)
- 8-K reportMay 6, 2026